Ashwagandha for Cognitive Function

Verdict: Promising but unproven for cognition

Ashwagandha shows encouraging early signals for memory and attention, but the evidence is weak and disputed: studies are small and industry-funded, and major health authorities still say there isn't enough proof to recommend it for cognitive function.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

This claim lands at Tier C (Weak Evidence) with a "disputed" status because the human-trial signal and the official consensus point in opposite directions. A 2026 systematic review and meta-analysis (PMID frontiers-2026-1799467, n=1249) reported a moderate benefit for memory (SMD 0.52, 95% CI 0.27-0.78) plus smaller gains in attention/processing speed and executive function. Three supporting double-blind RCTs agree, in adults with mild cognitive impairment (PMID 40099725), in a general adult sample at 600 mg/day (PMID 39498904), and in healthy stressed adults at 300 mg/day over 90 days (PMID 34858513).

The grade stays at C rather than rising because the evidence base is thin and conflicted. All three RCTs are industry-funded, sample sizes are modest (40-125), and the populations and doses are heterogeneous, which makes a manufacturer-driven or publication-bias effect hard to rule out. Notably, the cleanest mechanism is indirect: the healthy-adult trial showed lower cortisol, less stress, and better sleep alongside the memory gains.

Authoritative reviewers remain cautious, which drives the dispute. The NIH Office of Dietary Supplements frames the evidence around stress and cortisol rather than cognition ("ashwagandha extracts may lower stress, anxiety, and cortisol levels"), Cleveland Clinic states plainly "There isn't enough evidence," and the Alzheimer's Association maintains that "not a single food, beverage, ingredient, vitamin or supplement" is proven to help. The FDA lists only the botanical name with no GRAS status, and the WHO monograph records traditional use without endorsing a cognitive benefit. Bottom line: a real but unconfirmed signal, not an established treatment.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.54
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
81%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L5 Clinical bodiesAuthoritative stance
0.40
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L3 MechanismPlausibility
0.65
L2 PubMedPrimary literature
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.544
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 1 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Effects of Withania somnifera (Ashwagandha) on Cognitive and Physical Function in Adults: A Systematic Review and Meta-Analysis
PMID: 2026 統合分析 n = 1,249
— See PubMed for details
View on PubMed
Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
PMID: 40099725 2025 RCT (double-blind) n = 40
Finding: MoCA +14.77%, MMSE +19.21%, Shepard +31.67% at 60 days vs placebo (significant improvement reported)
⚠️ Industry-funded
View on PubMed
Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study
PMID: 39498904 2026 RCT (double-blind) n = 120
Finding: Ashwagandha superior to placebo on episodic memory, working memory, attention accuracy (p<0.05); secondary improvements in mood, mental fatigue, executive function
⚠️ Industry-funded
View on PubMed
Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study
PMID: 34858513 2021 RCT (double-blind) n = 125
Finding: Improved first-attempt memory 12.9 vs 10.1; reduced total errors 17.5 vs 27.7; reduced stress (p<0.0001), cortisol (p=0.0443), improved sleep (p<0.0001) and well-being (p<0.0001)
⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
WITHANIA SOMNIFERA ROOT source↗
L4d TW TFDA / 衛福部
Cautious
南非醉茄萃取物 source↗
L4e WHO
Neutral
WHO monographs on selected medicinal plants source↗
L5a NIH Office of Dietary Supplements
Cautious
ashwagandha extracts may lower stress, anxiety, and cortisol levels source↗
L5c Cleveland Clinic
Cautious
There isn't enough evidence source↗
L5e Specialty Society (condition-mapped)
Not addressed
Not a single food, beverage, ingredient, vitamin or supplement source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-cognitive-function-INT-ashwagandha-001 繁體中文版 →